Why is Akums Drugs falling/rising?

As of 02-Sep, Akums Drugs & Pharmaceuticals Ltd is experiencing a price increase, currently at Rs 472.05, reflecting a rise of Rs 4.95 or 1.06%. The stock has shown positive momentum recently, gaining 3.95% over the last two days and outperforming its sector by 1.13% today. However, despite this short-term gain, the stock has underperformed significantly over longer periods, with a year-to-date decline of 26.02% and a one-year drop of 43.31%. The company has a low debt-to-equity ratio and an attractive valuation with a price-to-book value of 2.4, but it has also faced challenges, including a 21.6% decline in PAT for the most recent quarter and flat sales growth over the past five years.
In the broader market context, the stock's recent performance contrasts with the benchmark Sensex, which has shown a slight decline of 0.78% over the past week and a modest gain of 2.58% year-to-date. While Akums Drugs has outperformed the sector in the short term, its long-term performance remains concerning, as indicated by its significant losses compared to the benchmark indices over various time frames. The falling investor participation, with a 55.99% drop in delivery volume against the five-day average, further highlights the challenges the stock faces in attracting sustained interest from investors.